These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 30649034)

  • 21. The cost-effectiveness of multi-purpose HIV and pregnancy prevention technologies in South Africa.
    Quaife M; Terris-Prestholt F; Eakle R; Cabrera Escobar MA; Kilbourne-Brook M; Mvundura M; Meyer-Rath G; Delany-Moretlwe S; Vickerman P
    J Int AIDS Soc; 2018 Mar; 21(3):. PubMed ID: 29537654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluating the potential impact and cost-effectiveness of dapivirine vaginal ring pre-exposure prophylaxis for HIV prevention.
    Reidy M; Gardiner E; Pretorius C; Glaubius R; Torjesen K; Kripke K
    PLoS One; 2019; 14(6):e0218710. PubMed ID: 31242240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness and budget impact of the community-based management of hypertension in Nepal study (COBIN): a retrospective analysis.
    Krishnan A; Finkelstein EA; Kallestrup P; Karki A; Olsen MH; Neupane D
    Lancet Glob Health; 2019 Oct; 7(10):e1367-e1374. PubMed ID: 31537367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modelling the impact and cost-effectiveness of the HIV intervention programme amongst commercial sex workers in Ahmedabad, Gujarat, India.
    Fung IC; Guinness L; Vickerman P; Watts C; Vannela G; Vadhvana J; Foss AM; Malodia L; Gandhi M; Jani G
    BMC Public Health; 2007 Aug; 7():195. PubMed ID: 17683595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV/AIDS in Côte d'Ivoire: a trial-based analysis.
    Yazdanpanah Y; Losina E; Anglaret X; Goldie SJ; Walensky RP; Weinstein MC; Toure S; Smith HE; Kaplan JE; Freedberg KA;
    AIDS; 2005 Aug; 19(12):1299-308. PubMed ID: 16052085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of HIV treatment in resource-poor settings--the case of Côte d'Ivoire.
    Goldie SJ; Yazdanpanah Y; Losina E; Weinstein MC; Anglaret X; Walensky RP; Hsu HE; Kimmel A; Holmes C; Kaplan JE; Freedberg KA
    N Engl J Med; 2006 Sep; 355(11):1141-53. PubMed ID: 16971720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of nevirapine to prevent mother-to-child HIV transmission in eight African countries.
    Sweat MD; O'Reilly KR; Schmid GP; Denison J; de Zoysa I
    AIDS; 2004 Aug; 18(12):1661-71. PubMed ID: 15280777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An application of a proposed framework for formulary listing in low-income countries: the case of Côte d'Ivoire.
    Diaby V; Lachaine J
    Appl Health Econ Health Policy; 2011 Nov; 9(6):389-402. PubMed ID: 22017499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cost-effectiveness of monitoring strategies for antiretroviral therapy of HIV infected patients in resource-limited settings: software tool.
    Estill J; Salazar-Vizcaya L; Blaser N; Egger M; Keiser O
    PLoS One; 2015; 10(3):e0119299. PubMed ID: 25793531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of HIV infection and associated factors among female sex workers in Côte d'Ivoire, results of the ANRS 12361 PrEP-CI study using recent infection assays.
    Nouaman MN; Becquet V; Plazy M; Coffie PA; Zébago C; Montoyo A; Anoma C; Eholié S; Dabis F; Larmarange J;
    PLoS One; 2022; 17(11):e0271988. PubMed ID: 36395099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modelling the Epidemiological Impact and Cost-Effectiveness of PrEP for HIV Transmission in MSM in China.
    Zhang L; Peng P; Wu Y; Ma X; Soe NN; Huang X; Wu H; Markowitz M; Meyers K
    AIDS Behav; 2019 Feb; 23(2):523-533. PubMed ID: 29971734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physical and Sexual Violence Affecting Female Sex Workers in Abidjan, Côte d'Ivoire: Prevalence, and the Relationship with the Work Environment, HIV, and Access to Health Services.
    Lyons CE; Grosso A; Drame FM; Ketende S; Diouf D; Ba I; Shannon K; Ezouatchi R; Bamba A; Kouame A; Baral S
    J Acquir Immune Defic Syndr; 2017 May; 75(1):9-17. PubMed ID: 28169873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of past HIV interventions and diagnosis gaps on new HIV acquisitions, transmissions, and HIV-related deaths in Côte d'Ivoire, Mali, and Senegal.
    Silhol R; Maheu-Giroux M; Soni N; Fotso AS; Rouveau N; Vautier A; Doumenc-Aïdara C; Geoffroy O; N'Guessan KN; Sidibé Y; Kabemba OK; Gueye PA; Ndeye PD; Mukandavire C; Vickerman P; Keita A; Ndour CT; Ehui E; Larmarange J; Boily MC;
    AIDS; 2024 Oct; 38(12):1783-1793. PubMed ID: 38953898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preliminary cost-effectiveness analysis of an AIDS vaccine in Abidjan, Ivory Coast.
    Cowley P
    Health Policy; 1993 May; 24(2):145-53. PubMed ID: 10128800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-Effectiveness of the 'One4All' HIV Linkage Intervention in Guangxi Zhuang Autonomous Region, China.
    Zang X; Tang H; Min JE; Gu D; Montaner JS; Wu Z; Nosyk B
    PLoS One; 2016; 11(11):e0167308. PubMed ID: 27893864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acceptance of HIV in Cote d'Ivoire earns praise.
    AIDS Wkly Plus; 1996 Apr; ():15-6. PubMed ID: 12290906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An urgent need for integration of family planning services into HIV care: the high burden of unplanned pregnancy, termination of pregnancy, and limited contraception use among female sex workers in Côte d'Ivoire.
    Schwartz S; Papworth E; Thiam-Niangoin M; Abo K; Drame F; Diouf D; Bamba A; Ezouatchi R; Tety J; Grover E; Baral S
    J Acquir Immune Defic Syndr; 2015 Mar; 68 Suppl 2():S91-8. PubMed ID: 25723996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assisted partner notification services are cost-effective for decreasing HIV burden in western Kenya.
    Sharma M; Smith JA; Farquhar C; Ying R; Cherutich P; Golden M; Wamuti B; Bukusi D; Spiegel H; Barnabas RV
    AIDS; 2018 Jan; 32(2):233-241. PubMed ID: 29135576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Results from a rapid national assessment of services for the prevention of mother-to-child transmission of HIV in Côte d'Ivoire.
    Granato SA; Gloyd S; Robinson J; Dali SA; Ahoba I; Aka D; Kouyaté S; Billy DA; Kalibala S; Koné A
    J Int AIDS Soc; 2016; 19(5 Suppl 4):20838. PubMed ID: 27443269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness analysis of strategies to manage the disease burden of hepatitis C virus in Switzerland.
    Blach S; Schaetti C; Bruggmann P; Negro F; Razavi H
    Swiss Med Wkly; 2019 Mar; 149():w20026. PubMed ID: 30905063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.